Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
3199 |
|
| Actual shortage: | 254 (8%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2934 (92%) | |
Discontinuation Reports |
435 |
|
| To be discontinued: | 2 (0%) | |
| Discontinued: | 410 (94%) | |
| Reversed: | 23 (5%) | |
Late reports |
482 (13%) |
|
Overdue reports |
12 (5%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-09-05 | 2020-02-08 | 93146 |
| TEVA-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2020-05-01 | 2020-06-11 | 113803 |
| TEVA-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2020-07-09 | 2023-04-28 | 119904 |
| TEVA-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2020-09-03 | 2020-09-24 | 123741 |
| TEVA-VORICONAZOLE | 200MG | TABLET | Resolved | 2019-08-22 | 2019-11-28 | 92163 |
| TEVA-VORICONAZOLE | 200MG | TABLET | Resolved | 2020-07-16 | 2020-08-21 | 120456 |
| TEVA-VORICONAZOLE | 50MG | TABLET | Resolved | 2021-07-08 | 2021-08-24 | 142204 |
| TEVA-VORICONAZOLE | 50MG | TABLET | Resolved | 2021-07-15 | 2021-09-02 | 142628 |
| TEVA-VORICONAZOLE | 200MG | TABLET | Resolved | 2022-06-03 | 2023-04-28 | 161976 |
| TEVA-VORICONAZOLE | 50MG | TABLET | Resolved | 2022-06-09 | 2023-04-28 | 162309 |
| TEVA-VORICONAZOLE | 200MG | TABLET | Resolved | 2023-07-27 | 2025-04-29 | 200307 |
| TEVA-VORICONAZOLE | 50MG | TABLET | Resolved | 2023-10-19 | 2025-04-29 | 207545 |
| TEVA-VORICONAZOLE | 50MG | TABLET | Resolved | 2024-05-09 | 2025-04-29 | 227500 |
| TEVA-VORICONAZOLE | 200MG | TABLET | Resolved | 2024-05-09 | 2025-04-29 | 227503 |
| TEVA-ZOLMITRIPTAN | 2.5MG | TABLET | Resolved | 2020-04-23 | 2020-05-08 | 113019 |
| TEVA-ZOLMITRIPTAN | 2.5MG | TABLET | Resolved | 2020-09-24 | 2020-10-22 | 125016 |
| TEVA-ZOLMITRIPTAN | 2.5MG | TABLET | Resolved | 2022-08-18 | 2023-04-28 | 167200 |
| TEVA-ZOLMITRIPTAN OD | 2.5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-03-13 | 2020-02-13 | 1674 |
| TEVA-ZOLMITRIPTAN OD | 2.5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2020-10-22 | 2020-11-26 | 126933 |
| TEVA-ZOLMITRIPTAN OD | 2.5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2021-09-30 | 2021-10-07 | 146472 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-VALSARTAN | 40MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258501 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255827 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255830 |
| TEVA-VALSARTAN/HCTZ | 25MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255833 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256140 |
| TEVA-VALSARTAN/HCTZ | 25MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256143 |
| TEVA-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-02-07 | 2020-02-08 | 105537 |
| TEVA-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-06-11 | 2020-06-11 | 117546 |
| TEVA-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-09-24 | 2020-09-24 | 124899 |
| TEVA-VORICONAZOLE | 200MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256166 |
| TEVA-VORICONAZOLE | 50MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256169 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-09-27 | 2019-10-01 | 94980 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-10-17 | 2019-10-17 | 96695 |
| ZOLEDRONIC ACID FOR INJECTION | 4MG | SOLUTION | Discontinued | 2025-05-28 | 2025-05-28 | 258583 |
| ZOLEDRONIC ACID INJECTION | 5MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14030 |